Janux Therapeutics Inc.

29.04
-0.74 (-2.48%)
At close: Mar 28, 2025, 3:59 PM
27.37
-5.73%
Pre-market: Mar 31, 2025, 08:46 AM EDT

Janux Therapeutics Ratios Statement

Year FY24 FY23 FY22 FY21 FY20 FY19
PE Ratio -41.71 -8.1 -10.09 -24.99 -199.15 -247
PEG Ratio 13.76 -10.61 -0.15 -0.05 -6.64 n/a
PS Ratio 271.80 58.43 63.42 223.74 n/a n/a
PB Ratio 2.81 1.37 1.70 2.22 -71.49 -131.74
P/FCF Ratio -65.15 -9.01 -11.06 -44.09 -239.54 -273.39
P/OCF Ratio -65.68 -9.34 -12.72 -47.93 -239.54 -273.39
OCF/S Ratio -4.14 -6.26 -4.98 -4.67 n/a n/a
Debt / Equity Ratio 0.02 0.07 0.08 0.00 n/a -0.5
Quick Ratio 59.21 26.80 20.18 29.48 5.05 0.14
Current Ratio 59.21 26.80 20.14 29.46 5.05 0.14
Asset Turnover 0.01 0.02 0.02 0.01 n/a n/a
Interest Coverage n/a n/a -16.64 n/a -23.51 -16.18
Return on Equity (ROE) -0.07 -0.17 -0.17 -0.09 0.36 0.53
Return on Assets (ROA) -0.06 -0.15 -0.15 -0.09 -0.32 -6.24
Return on Capital (ROIC) -0.09 -0.2 -0.19 -0.09 -0.37 0.96
Dividend Yield n/a n/a n/a n/a n/a n/a
Payout Ratio n/a n/a n/a n/a n/a n/a
Gross Profit Margin 100.00% 75.81% 90.23% 96.89% n/a n/a
Net Profit Margin -651.62% -721.18% -628.82% -895.22% n/a n/a
Pretax Profit Margin -651.62% -721.18% -732.22% -898.32% n/a n/a
Operating Profit Margin -933.58% -902.87% -779.04% -905.39% n/a n/a
FCF Margin -417.2% -648.58% -573.24% -507.51% n/a n/a
EBITDA Margin -933.58% -878.68% -769.28% -902.28% n/a n/a